Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma

Oncology

Volumn 63, Issue 4, 2002, Pages 353-361

  Okuyama, Toshiro ^a   Maehara, Yoshihiko ^a   Kabashima, Akira ^a   Takahashi, Ikuo ^a   Kakeji, Yoshihiro ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Gastric cancer, prognosis; p21; p53; Signal pathway

Indexed keywords

ANTIBODY; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME;

AGED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036968039     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066223     Document Type: Article

References (18)

1. Fu CG, Tominaga O, Nagawa H, Nita ME, Masaki T, Ishimaru G, Higuchi Y, Tsuruo T, Muto T: Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 1998;41:68-74.
2. Cayrol C, Knibiehler M, Ducommun B: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 1998; 16:311-320.
3. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N: Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric cancer. Dig Dis Sci 1998;43:964-970.
4. Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano M, Nakamura Y, Tokino T: A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997;15: 2145-2150.
5. Velasco-Miguel S, Buckbinder L, Jean P, Gilbert L, Talbott R, Laidlaw J, Seizinger B, Kley N: PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth-arrest inducible genes. Oncogene 1999;18:127-137.
6. Maehara Y, Tomoda M, Hasuda S, Kabashima A, Tokunaga E, Kakeji Y, Sugimachi K: Prognostic value of p53 protein expression for patients with gastric cancer - A multivariate analysis. Br J Cancer 1999;79:1255-1261.
7. WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer 1997;75:1617-1620.
8. Qin LF, Ng IO, Fan ST, Ng M: p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer 1998; 79:424-428.
9. WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis. Pathol Res Pract 1998; 194:309-317.
10. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, 2nd Engl ed. Gastric Cancer 1998;1:10-24.
11. Hermanek P, Sobin LH: TNM Classification of malignant tumors, ed 4. Geneva, Union Internationale Contre le Cancer (UICC), 1987, pp 43-46.
12. Toh Y, Kuwano H, Sonoda K, Saeki H, Kawaguchi H, Kitamura K, Nakashima H, Sugimachi K: Correlation between reduced p21 expression and abnormal p53 expression in esophageal carcinomas. Int J Oncol 1997;11: 703-708.
13. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K: Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 1993;67:589-593.
14. waf1 expression and growth inhibition by transforming growth factor-β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997;57:3929-3934.
15. WAF1/CIP1 expression by p53-independent pathways. Oncogene 1996;12:1557-1564.
16. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Palma PD, Bevilacqua G: p21 RNA and protein expression in non-small cell lung carcinomas: Evidence of p53-independent expression and association with tumoral differentiation. Oncogene 1996;12:1319-1324.
17. WAF1 and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res 1996;2:1591-1599.
18. Di Giuseppe JA, Redston MS, Yeo CJ, Kern SE, Hurban RH: p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 1995;147: 884-888.